Let’s start up with the current stock price of Artelo Biosciences Inc. (ARTL), which is $1.11 to be very precise. The Stock rose vividly during the last session to $1.05 after opening rate of $1.05 while the lowest price it went was recorded $1.00 before closing at $1.03.Recently in News on July 21, 2021, Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences’ CAReS Study on July 28, 2021. Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that Ladenburg Thalmann & Co. Inc. will host an R&D showcase focused on the Phase 1b/2a Cancer Appetite Recovery Study (“CAReS”), evaluating the Company’s lead drug candidate, ART27.13. The webinar will be hosted by Michael Higgins, Managing Director and Senior Biopharmaceutical Equity Research Analyst on July 28th, 2021 at 1pm EDT/10am PDT. This event will include the lead investigator on the CAReS study, Barry Laird, PhD, a Senior Clinical Consultant of Palliative Medicine at St Columba’s Hospice Care in Edinburg, UK. Among a number of key topics, Dr. Laird will be discussing the etiology of anorexia and the accompanying challenges of effectively treating anorexia. You can read further details here
Artelo Biosciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.6700 on 02/12/21, with the lowest value was $0.7460 for the same time period, recorded on 01/04/21.
Artelo Biosciences Inc. (ARTL) full year performance was -8.85%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Artelo Biosciences Inc. shares are logging -69.75% during the 52-week period from high price, and 146.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.45 and $3.67.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2191677 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Artelo Biosciences Inc. (ARTL) recorded performance in the market was 41.10%, having the revenues showcasing -24.26% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 26.21M, as it employees total of 4 workers.
The Analysts eye on Artelo Biosciences Inc. (ARTL)
During the last month, 0 analysts gave the Artelo Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3328, with a change in the price was noted -0.40. In a similar fashion, Artelo Biosciences Inc. posted a movement of -25.99% for the period of last 100 days, recording 955,478 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARTL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Artelo Biosciences Inc. (ARTL)
Raw Stochastic average of Artelo Biosciences Inc. in the period of last 50 days is set at 45.88%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 64.68%. In the last 20 days, the company’s Stochastic %K was 37.86% and its Stochastic %D was recorded 27.79%.
Considering, the past performance of Artelo Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 41.10%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -2.83%, alongside a downfall of -8.85% for the period of the last 12 months. The shares increased approximately by 0.98% in the 7-day charts and went up by -18.25% in the period of the last 30 days. Common stock shares were lifted by -24.26% during last recorded quarter.